Unichem Laboratories receives ANDA approval for Nebivolol Tablets

Unichem Laboratories Limited has received ANDA approval for its Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Bystolic® (nebivolol) Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg, of Allergan Sales, LLC.

Nebivolol Tablets are indicated for the treatment of hypertension. The product will be commercialized from Unichem's Ghaziabad Plant.

Shares of Unichem Laboratories Limited was last trading in BSE at Rs. 245.45 as compared to the previous close of Rs. 253.90. The total number of shares traded during the day was 42014 in over 3950 trades.

The stock hit an intraday high of Rs. 262.05 and intraday low of 243.60. The net turnover during the day was Rs. 10420025.00.

Source : Equity Bulls

Keywords

UnichemLaboratories INE351A01035 ANDAApproval NebivololTablets USFDA